Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 4, 2006, Pages 891-896

  Zheng, Chunyu ^a   Murdoch, Susan J ^b   Brunzell, John D ^b   Sacks, Frank M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ApoB lipoproteins; Apolipoprotein E; Dietary fats; Lipoprotein lipase; Postprandial response

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; ENZYME BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOAFFINITY CHROMATOGRAPHY; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR BINDING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; BIOLOGICAL TRANSPORT; BODY MASS INDEX; FEMALE; HUMANS; LACTONES; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; PARTICLE SIZE; POSTPRANDIAL PERIOD; PROTEIN BINDING;

EID: 33646689532     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000203512.01007.3d     Document Type: Article

References (25)

1. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo CII deficiency and hepatic lipase deficiency, in The Metabolic and Molecular Basis of Inherited Diseases. In: Sciver C, ed. New York: McGraw-Hill Book Co; 2000:2789-2816.
2. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37:693-707.
3. Pedersen ME, Cohen M, Schotz MC. Immunocytochemical localization of the functional fraction of lipoprotein lipase in the perfused heart. J Lipid Res. 1983;24:512-521.
4. Zambon A, Schmidt I, Beisiegel U, Brunzell JD. Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins. J Lipid Res. 1996;37:2394-2404.
5. Kern PA, Martin RA, Carty J, Goldberg IJ, Ong JM. Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia. J Lipid Res. 1990;31:17-26.
6. Felts JM, Itakura H, Crane RT. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants-a new theory. Biochem Biophys Res Commun. 1975;66:1467-1475.
7. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A. 1991;88:8342-8346.
8. Chappell DA, Inoue I, Fry GL, Pladet MW, Iverius PH, Lalouel JM, Strickland DK. The carboxy-terminal domain of lipoprotein lipase induces cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Ann N Y Acad Sci. 1994;737:434-438.
9. Chappell DA, Inoue I, Fry GL, Pladet MW, Bowen SL, Iverius PH, Lalouel JM, Strickland DK. Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem. 1994;269:18001-18006.
10. Nykjaer A, Nielsen M, Lookene A, Meyer N, Roigaard H, Etzerodt M, Beisiegel U, Olivecrona G, Gliemann J. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. J Biol Chem. 1994;269:31747-31755.
11. Skottova N, Savonen R, Lookene A, Hultin M, Olivecrona G. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J Lipid Res. 1995;36:1334-1344.
12. Merkel M, Kako Y, Radner H, Cho IS, Ramasamy R, Brunzell JD, Goldberg IJ, Breslow JL. Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci U S A. 1998;95:13841-13846.
13. Heeren J, Niemeier A, Merkel M, Beisiegel U. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo. J Mol Med. 2002;80:576-584.
14. Khoo C, Campos H, Judge H, Sacks FM. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res. 1999;40:202-212.
15. Campos H, Perlov D, Khoo C, Sacks FM. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res. 2001;42:1239-1249.
16. Vilella E, Joven J. Lipoprotein lipase binding to plasma lipoproteins. Med Sci Res. 1991;19:111-112.
17. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-485.
18. Karpe F, Olivecrona T, Olivecrona G, Samra JS, Summers LK, Humphreys SM, Frayn KN. Lipoprotein lipase transport in plasma: role of muscle and adipose tissues in regulation of plasma lipoprotein lipase concentrations. J Lipid Res. 1998;39:2387-2393.
19. Kobayashi J, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y, Yoshida S. Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta. 1993;216(1-2):113-123.
20. Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K. Pre-heparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias. Atherosclerosis. 1999;145:45-50.
21. Brunzell JD, Hazzard WR, Porte Jr D, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973;52:1578-1585.
22. Shachter NS. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol. 2001;12:297-304.
23. Haberbosch W, Poli A, Augustin J. Characterization of human chylomicrons. Biochim Biophys Acta. 1982;713:398-409.
24. Jackson RL, McLean LR, Demel RA. Mechanism of action of lipoprotein lipase and hepatic triglyceride lipase. Am Heart J. 1987;113(2Pt2):551-554.
25. Fruchart-Najib J, Bauge E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, Fruchart JC. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun. 2004;319:397-404.